These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2273204)

  • 1. Calcitonin and estrogens.
    Agnusdei D; Civitelli R; Camporeale A; Gennari C
    J Endocrinol Invest; 1990 Sep; 13(8):625-30. PubMed ID: 2273204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin, estrogens and the bone.
    Gennari C; Agnusdei D
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):451-5. PubMed ID: 2257249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.
    Civitelli R; Agnusdei D; Nardi P; Zacchei F; Avioli LV; Gennari C
    Calcif Tissue Int; 1988 Feb; 42(2):77-86. PubMed ID: 3127028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
    Fletcher CD; Farish E; Leggate J; Hart DM
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):353-6. PubMed ID: 2031433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin and postmenopausal osteoporosis.
    Leggate J; Farish E; Fletcher CD; McIntosh W; Hart DM; Sommerville JM
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):85-92. PubMed ID: 6362926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estrogens and calcium on calcitonin secretion in postmenopausal women.
    Body JJ; Struelens M; Borkowski A; Mandart G
    J Clin Endocrinol Metab; 1989 Jan; 68(1):223-6. PubMed ID: 2909552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic therapy of osteoporosis].
    Kushida K
    Nihon Rinsho; 1994 Sep; 52(9):2367-77. PubMed ID: 7967083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects in postmenopausal women of natural and synthetic estrogens on calcitonin and calcium-regulating hormone secretion. Relevance to postmenopausal osteoporosis.
    Whitehead MI; Lane G; Townsend PT; Abeyasekera G; Hillyard CJ; Stevenson JC
    Acta Obstet Gynecol Scand Suppl; 1981; 106():27-32. PubMed ID: 6951874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The late effect of subtotal thyroidectomy and radioactive iodine therapy on calcitonin secretion and bone mineral density in women treated for Graves' disease.
    Lowery WD; Thomas CG; Awbrey BJ; Rosenstein BD; Talmage RV
    Surgery; 1986 Dec; 100(6):1142-9. PubMed ID: 3787472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosis.
    Gennari C
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():61-5. PubMed ID: 2667872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of endogenous calcitonin in postmenopausal osteoporosis].
    Body JJ; Mandart G; Struelens M; Heath H; Borkowski A
    Rev Med Brux; 1987; 8(6-7):325-8. PubMed ID: 3671923
    [No Abstract]   [Full Text] [Related]  

  • 15. Postmenopausal osteoporosis: response of immunoextracted calcitonin to a calcium clamp.
    Sjöberg HE; Tørring O; Granberg B; Ehrnsten U; Bucht E
    Bone; 1989; 10(1):15-8. PubMed ID: 2660882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin secretion in postmenopausal osteoporosis.
    Tiegs RD; Body JJ; Wahner HW; Barta J; Riggs BL; Heath H
    N Engl J Med; 1985 Apr; 312(17):1097-100. PubMed ID: 3982469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.
    Pacifici R; McMurtry C; Vered I; Rupich R; Avioli LV
    J Clin Endocrinol Metab; 1988 Apr; 66(4):747-53. PubMed ID: 3126214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.